Flurisone 0.1% Eye Drop – Relief for Redness and Swelling
Flurisone 0.1% Eye Drop is a steroid-based eye medication designed to reduce inflammation, redness, and swelling caused by infections, allergies, or eye surgery. It soothes itching, discomfort, and irritation, helping you maintain clear and healthy vision.
Uses
-
Reduces eye redness and swelling
-
Relieves irritation and itching due to infections or allergies
-
Supports recovery after eye surgery or injury
Benefits
-
Provides fast relief from redness, pain, and swelling
-
Alleviates discomfort caused by itching and watering of the eyes
-
Helps you carry on daily activities with less eye irritation
-
Promotes healing by controlling inflammation
How It Works
Flurisone 0.1% Eye Drop is a steroid that blocks the release of inflammatory chemical messengers called prostaglandins. This reduces swelling, redness, and irritation, providing effective relief from eye discomfort.
How to Use
-
Wash hands thoroughly before use.
-
Remove contact lenses and wait at least 15 minutes before reinserting them.
-
Hold the dropper close to the eye without touching it.
-
Place the drop in the lower eyelid and gently close the eye.
-
Wipe off any excess liquid.
-
Follow the dosing schedule prescribed by your doctor for maximum benefit.
Safety Information
-
Temporary side effects may include eye irritation or blurred vision.
-
Avoid driving or operating machinery until vision clears after use.
-
Consult your doctor before use if you are pregnant or breastfeeding.
-
Do not use if the seal is broken before first use.
-
Complete the full course as prescribed to achieve the best results.
Missed Dose
If a dose is missed, apply it as soon as possible. If it is nearly time for the next dose, skip the missed dose and continue with your regular schedule. Do not double the dose.
Product Variants & Keywords
Keywords: Flurisone 0.1% Eye Drop, Eye redness relief drops, Anti-inflammatory eye drops, Swelling reduction eye drops, Allergy eye drops, Post-surgery eye drops
Reviews
There are no reviews yet.